Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05104866 |
|---|---|
| Brief Title: | A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01) |
| First Submitted : | October 4, 2021 |
| First Submitted that Met QC Criteria : | November 2, 2021 |
| First Posted : | November 3, 2021 |
| Last Update Submitted that Met QC Criteria : | April 22, 2024 |
| Last Update Posted : | April 23, 2024 |